Tag: Sexually Transmitted Diseases: AIDS/HIV
In AIDS-Related Lymphoma, Outcomes Worse With Hypoalbuminemia
AIDS-related lymphoma patients with hypoalbuminemia show worse overall survival, two-year progression-free survival
Decrease Seen in HIV Testing, Diagnoses During Pandemic
Decreases seen in priority populations including Black gay men, Hispanic gay men, bisexual men, MSM, transgender persons
Treating Anal HSIL Cuts Anal Cancer Risk in Persons With HIV
Rate of progression to anal cancer lower for those receiving treatment of anal high-grade squamous intraepithelial lesions
Risk for SARS-CoV-2 Breakthrough Infections Up in Persons With HIV
Risk for breakthrough infections increased in association with younger age, history of COVID-19, not receiving additional vaccine dose
Lenacapavir Reduces Viral Load in Multidrug-Resistant HIV-1 Infection
Reduction in viral load from baseline greater with lenacapavir versus placebo among those with multidrug-resistant HIV-1 infection
FDA Approves Marketing of First Condom Designed for Anal Sex
Condom was approved through the De Novo premarket review pathway for low- to moderate-risk devices of a new type
Woman Cured of HIV After Umbilical Cord Blood Transplant
Cord blood contained a mutation that blocks HIV entry into cells and came from a partially matched donor
First Shots Given in Trial of Moderna mRNA-Based HIV Vaccine
Vaccine uses mRNA technology to deliver HIV-specific antigens that could trigger an immune response against the virus
Long-Acting Cabotegravir Not Necessarily Cost-Effective for PrEP
Benefits do not necessarily justify large price difference compared with generic F/TDF for men who have sex with men and transgender women
Dolutegravir-Based ART Superior for Children, Teens With HIV
Rate of serious adverse events similar for participants receiving dolutegravir, standard care as first-, second-line treatment for HIV-1 infection
